These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23077667)

  • 1. Genetic KCa3.1-deficiency produces locomotor hyperactivity and alterations in cerebral monoamine levels.
    Lambertsen KL; Gramsbergen JB; Sivasaravanaparan M; Ditzel N; Sevelsted-Møller LM; Oliván-Viguera A; Rabjerg M; Wulff H; Köhler R
    PLoS One; 2012; 7(10):e47744. PubMed ID: 23077667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1.
    Coleman N; Brown BM; Oliván-Viguera A; Singh V; Olmstead MM; Valero MS; Köhler R; Wulff H
    Mol Pharmacol; 2014 Sep; 86(3):342-57. PubMed ID: 24958817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
    Sankaranarayanan A; Raman G; Busch C; Schultz T; Zimin PI; Hoyer J; Köhler R; Wulff H
    Mol Pharmacol; 2009 Feb; 75(2):281-95. PubMed ID: 18955585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+ -activated K+ -channels.
    Hasenau AL; Nielsen G; Morisseau C; Hammock BD; Wulff H; Köhler R
    Acta Physiol (Oxf); 2011 Sep; 203(1):117-26. PubMed ID: 21362152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.
    Oliván-Viguera A; Valero MS; Murillo MD; Wulff H; García-Otín AL; Arbonés-Mainar JM; Köhler R
    PLoS One; 2013; 8(3):e58614. PubMed ID: 23516517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Cardiovascular Function in Primary Hypertension in Rat by SKA-31, an Activator of
    Kloza M; Baranowska-Kuczko M; Toczek M; Kusaczuk M; Sadowska O; Kasacka I; Kozłowska H
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs.
    Damkjaer M; Nielsen G; Bodendiek S; Staehr M; Gramsbergen JB; de Wit C; Jensen BL; Simonsen U; Bie P; Wulff H; Köhler R
    Br J Pharmacol; 2012 Jan; 165(1):223-34. PubMed ID: 21699504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of KCa3.1 by SKA-31 induces arteriolar dilatation and lowers blood pressure in normo- and hypertensive connexin40-deficient mice.
    Radtke J; Schmidt K; Wulff H; Köhler R; de Wit C
    Br J Pharmacol; 2013 Sep; 170(2):293-303. PubMed ID: 23734697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Determinants for the Selectivity of the Positive KCa3.1 Gating Modulator 5-Methylnaphtho[2,1-
    Brown BM; Shim H; Zhang M; Yarov-Yarovoy V; Wulff H
    Mol Pharmacol; 2017 Oct; 92(4):469-480. PubMed ID: 28760780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension in wild type mice and animals with genetic deficit in KCa2.3 and KCa3.1 channels.
    Wandall-Frostholm C; Skaarup LM; Sadda V; Nielsen G; Hedegaard ER; Mogensen S; Köhler R; Simonsen U
    PLoS One; 2014; 9(5):e97687. PubMed ID: 24858807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Myogenic Tone in Rat Cremaster and Cerebral Arteries by SKA-31, an Activator of Endothelial KCa2.3 and KCa3.1 Channels.
    Mishra RC; Wulff H; Hill MA; Braun AP
    J Cardiovasc Pharmacol; 2015 Jul; 66(1):118-27. PubMed ID: 25815673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Channelopathy of small- and intermediate-conductance Ca
    Nam YW; Downey M; Rahman MA; Cui M; Zhang M
    Acta Pharmacol Sin; 2023 Feb; 44(2):259-267. PubMed ID: 35715699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SKA-31, an activator of endothelial Ca
    Khaddaj-Mallat R; Mathew John C; Braun AP
    Eur J Pharmacol; 2018 Jul; 831():60-67. PubMed ID: 29753043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications.
    Wulff H; Kolski-Andreaco A; Sankaranarayanan A; Sabatier JM; Shakkottai V
    Curr Med Chem; 2007; 14(13):1437-57. PubMed ID: 17584055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Channelopathy-causing mutations in the S
    Orfali R; Nam YW; Nguyen HM; Rahman MA; Yang G; Cui M; Wulff H; Zhang M
    Cell Calcium; 2022 Mar; 102():102538. PubMed ID: 35030515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hyperactive syndrome: metanalysis of genetic alterations, pharmacological treatments and brain lesions which increase locomotor activity.
    Viggiano D
    Behav Brain Res; 2008 Dec; 194(1):1-14. PubMed ID: 18656502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the Ca²⁺-dependent K⁺ channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury.
    Bouhy D; Ghasemlou N; Lively S; Redensek A; Rathore KI; Schlichter LC; David S
    J Neurosci; 2011 Nov; 31(45):16298-308. PubMed ID: 22072681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K
    Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH
    Pflugers Arch; 2016 Nov; 468(11-12):2041-2051. PubMed ID: 27592222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prominent role of KCa3.1 in endothelium-derived hyperpolarizing factor-type dilations and conducted responses in the microcirculation in vivo.
    Wölfle SE; Schmidt VJ; Hoyer J; Köhler R; de Wit C
    Cardiovasc Res; 2009 Jun; 82(3):476-83. PubMed ID: 19218287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal expression of the intermediate conductance calcium-activated potassium channel KCa3.1 in the mammalian central nervous system.
    Turner RW; Kruskic M; Teves M; Scheidl-Yee T; Hameed S; Zamponi GW
    Pflugers Arch; 2015 Feb; 467(2):311-28. PubMed ID: 24797146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.